Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
12 studies found for:    Peramivir
Show Display Options
Rank Status Study
1 Withdrawn Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Peramivir in Children With Influenza
Condition: Influenza
Intervention: Drug: Peramivir
2 Terminated A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.
Condition: Influenza
Interventions: Drug: Peramivir;   Drug: Placebo Comparator
3 Completed A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza
Condition: Acute, Uncomplicated Human Influenza
Interventions: Drug: Peramivir;   Drug: Placebo
4 Terminated Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza
Condition: Influenza
Interventions: Drug: Peramivir;   Drug: Placebo
5 Terminated A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza
Conditions: Cough;   Sore Throat;   Nasal Congestion;   Headache;   Fever;   Seasonal Influenza
Interventions: Drug: Peramivir 600mg Adults, Peramivir 10mg/kg Adolescents;   Drug: Placebo Peramivir
6 Withdrawn Pharmacokinetic Assessment of Peramivir in Hospitalized Adults Undergoing Continuous Renal Replacement Therapy
Conditions: Influenza;   Renal Failure
Intervention:
7 Completed Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza
Conditions: Seasonal Influenza;   Cough;   Sore Throat;   Nasal Congestion;   Myalgia;   Headache;   Fatigue
Intervention: Drug: Peramivir
8 Completed Evaluation of the Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening Influenza
Condition: Influenza
Intervention: Drug: Peramivir
9 Completed Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.
Condition: Influenza
Interventions: Drug: Peramivir 150mg;   Drug: Peramivir 300mg
10 Withdrawn Intramuscular Peramivir for the Treatment of Uncomplicated Influenza
Condition: Influenza
Interventions: Drug: Peramivir 150mg;   Drug: Peramivir 300mg
11 Completed Safety and Dose Study of Peramivir for Influenza Treatment
Condition: Influenza
Intervention: Drug: Peramivir
12 Unknown  Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients
Conditions: Virus Diseases;   Respiratory Tract Diseases;   Respiratory Tract Infections;   Influenza;   Orthomyxoviridae Infections
Interventions: Biological: split-virion, non-adjuvanted H1N1 vaccine of 15 μg;   Other: blood fix

Indicates status has not been verified in more than two years